John L Higgins's Net Worth

$68 Million

Estimate Recalculated Sep 18, 2024 06:57PM EST

Who is John L Higgins?

John L Higgins has an estimated net worth of $68 Million. This is based on reported shares across multiple companies, which include OmniAb, Inc., BIO-TECHNE Corp, LIGAND PHARMACEUTICALS INC, BIOCRYST PHARMACEUTICALS INC, and CONNETICS CORP.

SEC CIK

John L Higgins's CIK is 0001208906

Past Insider Trading and Trends

2022 was John L Higgins's most active year for acquiring shares with 27 total transactions. John L Higgins's most active month to acquire stocks was the month of September. 2022 was John L Higgins's most active year for disposing of shares, totalling 23 transactions. John L Higgins's most active month to dispose stocks was the month of July. 2012 saw John L Higgins paying a total of $2,324,837.02 for 186,666 shares, this is the most they've acquired in one year. In 2018 John L Higgins cashed out on 20,000 shares for a total of $1,879,173.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OmniAb, Inc. (OABI) Snapshot price: $3.97

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.77%
20K
—
—
2.62M
Jun 18
Form 4/A
+1,378.65%
2.43M
—
—
2.6M
Nov 1
Form 4
+0.56%
13.17K
—
—
2.35M
Jan 30
Form 4
+3.53%
83.72K
$3.36
$281,548.93
2.34M
Dec 28 - Jun 23
Form 4
—
0
$3.87
-$3,330.00
2.46M
May 23
Form 4
—
0
$3.87
-$370.00
2.46M
May 19
Form 4
—
0
$3.79
-$10,500.00
2.46M
May 18
Form 4
+1.63%
39.52K
—
—
2.46M
Jan 30
Form 4
∞
2.42M
$2.52
—
2.42M
Nov 1 - Nov 2
Form 3
—
0
—
—
0
No matching records found

BIO-TECHNE Corp (TECH) Snapshot price: $71.49

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.68%
4.13K
$48.08
$523.20
46.73K
Sep 12
Form 4
+16.39%
6K
$22.95
$137,700.00
42.61K
Jul 8
Form 4
—
0
$53.40
-$243,577.20
36.61K
May 14
Form 4
+4.65%
1.63K
—
—
36.61K
Oct 26
Form 4
+49.76%
11.62K
$50.86
-$34.76
34.98K
Apr 28
Form 4
+6.14%
338
—
—
5.84K
Oct 27
Form 4
+19.45%
896
$222.85
-$721,056.15
5.5K
Aug 10 - Aug 11
Form 4
—
0
$215.94
-$476,924.00
4.61K
Jun 7 - Jun 8
Form 4
+4.40%
194
—
—
4.61K
Oct 28
Form 4
—
0
$185.35
-$1,149,994.13
4.41K
Nov 6
Form 4
+9.72%
391
—
—
4.41K
Oct 29
Form 4
—
0
$133.35
-$718,832.50
4.02K
Feb 12
Form 4
+14.04%
495
—
—
4.02K
Oct 24
Form 4
—
0
$133.35
-$703,195.50
3.53K
Jun 4
Form 4
+17.07%
514
—
—
3.53K
Oct 25
Form 4
—
0
$124.50
-$1,268,373.00
3.01K
Aug 23
Form 4
+32.51%
739
—
—
3.01K
Oct 26
Form 4
+67.26%
914
—
—
2.27K
Oct 27
Form 4
-55.57%
-1.70K
$109.83
-$186,715.93
1.36K
Sep 8
Form 4
+52.95%
1.06K
—
—
3.06K
Oct 29
Form 4
+100.00%
1K
—
—
2K
Oct 30
Form 4
∞
1K
—
—
1K
Oct 31
Form 4
—
0
—
—
0
Oct 25
Form 4
—
0
—
—
0
Oct 27
Form 4
—
0
—
—
0
Oct 28
Form 4
—
0
—
—
0
Oct 29
Form 4
—
0
—
—
0
May 19
Form 3
—
0
—
—
0
No matching records found

LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $101.14

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.25%
-5.29K
$66.29
-$350,607.81
417.69K
Dec 28
Form 4
—
0
—
—
0
Dec 22
Form 4
-2.31%
-10.00K
$61.87
-$618,657.00
422.98K
Scheduled
Dec 16
Form 4
+3.85%
16.06K
$38.79
$28.80
432.98K
Dec 12
Form 4
-2.30%
-9.80K
$72.90
-$714,638.70
416.93K
Nov 30
Form 4
—
0
$45.55
-$655,373.00
426.73K
Scheduled
Nov 17 - Nov 18
Form 4/A
—
0
—
—
0
Form 4
+12.12%
45.92K
—
—
424.73K
Nov 1
Form 4/A
-0.27%
-1.00K
$88.06
-$88,060.00
366.18K
Sep 16
Form 4
-1.35%
-5.00K
$89.61
-$448,050.00
364.18K
Sep 15 - Sep 16
Form 4
+0.04%
164
$75.84
$12,437.27
369.18K
Jun 30
Form 4
+5.86%
20.42K
—
—
369.02K
Jun 10
Form 4
+2.35%
8K
$21.92
$175,360.00
348.59K
May 9 - May 10
Form 4
—
0
—
—
0
May 5
Form 4/A
—
0
—
—
0
Sep 19
Form 4/A
+6.72%
6K
—
—
95.28K
Feb 9
Form 3
—
0
—
—
0
No matching records found

BIOCRYST PHARMACEUTICALS INC (BCRX) Snapshot price: $8

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
Apr 30
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
May 11
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
May 12
Form 3
—
0
—
—
0
No matching records found

CONNETICS CORP No price found

EVP, Finance, Corp Dev. & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-114.37K
$17.50
-$2,001,492.50
0
Dec 28 - Dec 29
Form 4
-4.99%
-6.00K
—
—
114.12K
Dec 21
Form 4
+81.96%
60.86K
—
$60.86
135.12K
Feb 1
Form 4
+8.48%
5.81K
$6.03
$35,030.99
74.26K
Sep 2
Form 4
—
0
$10.89
-$205,241.83
68.45K
Scheduled
Aug 22
Form 4
-12.75%
-10.00K
$20.71
-$207,073.00
68.45K
Scheduled
Jun 10
Form 4
-1.45%
-1.15K
$18.40
-$21,236.48
78.45K
May 31
Form 4
—
0
$16.13
-$128,750.00
77.3K
Scheduled
Apr 19
Form 4
—
0
$15.60
-$98,800.00
77.3K
Scheduled
Mar 15
Form 4
—
0
—
—
0
Jan 18
Form 4
—
0
$13.01
-$243,875.00
167.09K
Scheduled
Jan 14
Form 4
+1.15%
881
$10.30
$9,076.06
77.3K
Nov 30
Form 4
—
0
$17.08
-$122,720.44
317.65K
Scheduled
Nov 10
Form 4
-8.94%
-7.50K
$26.62
-$199,662.75
76.42K
Scheduled
Nov 1
Form 4
+14.22%
10.45K
$15.68
-$774,697.71
83.92K
Scheduled
Jul 30 - Aug 2
Form 4
-11.98%
-10.00K
$20.77
-$207,739.00
73.47K
Scheduled
Jun 15
Form 4
+2.80%
2.27K
$10.30
$23,437.05
83.47K
May 28
Form 4
—
0
$15.56
-$68,069.00
81.19K
Scheduled
Mar 12
Form 4
+35.22%
21.15K
$12.94
-$3.05
81.19K
Feb 20
Form 4
—
0
$16.98
-$246,720.00
60.05K
Scheduled
Feb 9
Form 4
-24.98%
-15.00K
$12.57
-$477,699.00
45.05K
Scheduled
Jan 20 - Jan 21
Form 4
—
0
—
—
0
Jan 2
Form 4
-3.51%
-2.18K
$10.30
-$22,499.57
60.05K
Nov 28
Form 4
-14.74%
-10.00K
$19.00
-$190,000.00
57.86K
Scheduled
Oct 14
Form 4
+32.30%
16.63K
$11.32
-$1.52
68.11K
Sep 3
Form 4
—
0
—
—
0
No matching records found